Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs.


OBJECTIVE To assess the relationship between serum concentrations of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and osteoprotegerin (OPG) and the therapeutic response to disease-modifying antirheumatic drugs (DMARD) in patients with early rheumatoid arthritis (RA). METHODS Circulating levels of TRAIL and its soluble receptor OPG… (More)
DOI: 10.3899/jrheum.091363


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.